Thursday, October 19
Keynote 1: Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorders (FASD); Cresta Jones, MD
Breakout 1.1: A Recovery Journey from Methamphetamine Addiction: A Case Study of an Oneida Woman; Eric Smiltneek, MD, FASAM
Breakout 1.2: Evaluating the Impact of a Hospital-based Buprenorphine Consult Service in an Undeserved, High-need Urban Community; Delaney Weiland and Nathan Tunell
Breakout 2.1: OUD Treament and Training for Pregnancy and Parenting: Integrating MOUD into a Family Medicine Clinic; Maureen Longeway, MD, Susanne Krasovich, MD, Jessica Knipfer, NP, Colleen Allen, MSW, and Kristen Fox, MD
Breakout 2.2: Toxic Adulterants in the Drug Supply; Emily Brunner, MD, DFASAM, and Jeremiah Fairbanks, DO
Lunch Presentation: ASAM Regional Updates; Emily Brunner, MD, DFASAM
Breakout 3.1: Recovery Capital: From Theory to Implementation in a Post-Criminal Justice Involved Cohort; Nick Bormann, MD
Breakout 3.2: Analyzing the Effectiveness of Co-treatment of Hepatitis C Virus and Substance Use Disorder in an Addiction Medicine Clinic; Bonnie Nickash, APNP, RN, Allyson Ford, APNP, and Katie Linzmeier, RN
Breakout 4.1: Providing HOPE from the ED: A Project to Standardize Overdose Response in Wisconsin EDs; Ritu Bhatnagar, MD, MPH, FASAM, DFAPA
Breakout 4.2: Initiating Injectable Buprenorphine Extended-Release in a Community Hospital; Bryce d Venecia, MD, Francesco Tani, MD, DO, AAHIVS, and Sai Mistead, LSW
Keynote 2: What's New in Addiction Treatment: A View from SAMHSA; Yngvild Olsen, MD, MPH
Friday, October 19
Keynote 3: The Legalization of Marijuana: The Good, The Bad, and The Ugly; Doris Gunderson, MD
Breakout 5.1: Introduction to Physician Health Programs; Doris Gundersen, MD
Breakout 5.2: Harm Reduction: State of the Evidence; Elizabeth Salisbury-Afshar, MD, MPH
Breakout 6: Getting People to the Safety Zone: Community Naloxone Access and Connection to Peer Support; Cindy Burzinski, Executive Director - Wisconsin Voices for Recovery
Breakout 7.1: Recovery Homes: A Primer, a Pilot, and a Candid Discussion; Juleigh Nowinski Konchak, MD, MPH, FASAM, Lydia Karch, MPH, Daniel Walsh, MBA, NCRS, Jodie Dewey, PhD, and Vauna Hernandez, NCRS, CPRS
Breakout 7.2: Integrating a Community Methadone Program within a Federally Qualified Health Center; Brianna McQuade, PharmD, BCACP, MHPE, and Michael Huyck, DNP, FNP-APRN
Breakout 8.1: Co-occuring Psychiatric Conditions and Substance Use, What Non-Psychiatrists Need to Know; Allison Lynch, MD, MS
Breakout 8.2: Applying a Harm Reduction Philosophy to Clinical Work; Elizabeth Salisbury-Afshar, MD, MPH
Keynote 4: The Future of Addiction Medicine; Brian Hurley, MD